{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:53:03Z","timestamp":1792345983187,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":3531,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/ajt.12153","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T02:57:14Z","timestamp":1363316234000},"page":"1075-1079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody-Mediated Rejection"],"prefix":"10.1016","volume":"13","author":[{"given":"R.Y.","family":"Loyaga-Rendon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.O.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Koval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12153_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.410170407","article-title":"Progressive multifocal leukoencephalopathy: Clinical and radiographic features","volume":"17","author":"Krupp","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1111\/ajt.12153_bib2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1468-1331.2011.03597.x","article-title":"Progressive multifocal leukoencephalopathy: A review of the neuroimaging features and differential diagnosis","volume":"19","author":"Sahraian","year":"2012","journal-title":"Euro J Neurol"},{"key":"10.1111\/ajt.12153_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00007890-200002270-00001","article-title":"Immunosuppressive-associated leukoencephalopathy in organ transplant recipients","volume":"69","author":"Singh","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12153_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","article-title":"Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy","volume":"1","author":"Padgett","year":"1971","journal-title":"Lancet"},{"key":"10.1111\/ajt.12153_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0168-1702(84)90032-7","article-title":"Progressive multifocal leucoencephalopathy: Analysis of JC virus DNA from brain and kidney tissue","volume":"1","author":"Dorries","year":"1984","journal-title":"Virus Res"},{"key":"10.1111\/ajt.12153_bib6","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/jvi.64.6.3139-3143.1990","article-title":"Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals","volume":"64","author":"Yogo","year":"1990","journal-title":"J Virol"},{"key":"10.1111\/ajt.12153_bib7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/bmt.2009.381","article-title":"CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function","volume":"45","author":"Jing","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/ajt.12153_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneurol.2008.557","article-title":"Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy","volume":"66","author":"Cettomai","year":"2009","journal-title":"Arch Neurol"},{"issue":"Suppl 2","key":"10.1111\/ajt.12153_bib9","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/344280","article-title":"Traffic of JC virus from sites of initial infection to the brain: The path to progressive multifocal leukoencephalopathy","volume":"186","author":"Sabath","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12153_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11908-011-0196-6","article-title":"The changing landscape of progressive multifocal leukoencephalopathy","volume":"13","author":"Kedar","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/ajt.12153_bib11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1348-0421.1982.tb00254.x","article-title":"Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera","volume":"26","author":"Taguchi","year":"1982","journal-title":"Microbiol Immunol"},{"key":"10.1111\/ajt.12153_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"key":"10.1111\/ajt.12153_bib13","first-page":"93","article-title":"Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin\u2019s disease","volume":"81","author":"Astrom","year":"1958","journal-title":"Brain"},{"key":"10.1111\/ajt.12153_bib14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.0b013e3181f73600","article-title":"Incidence of progressive multifocal leukoencephalopathy in patients without HIV","volume":"75","author":"Amend","year":"2010","journal-title":"Neurology"},{"key":"10.1111\/ajt.12153_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-107-1-78","article-title":"Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases","volume":"107","author":"Berger","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.12153_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00687372","article-title":"Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases from Switzerland","volume":"77","author":"Lang","year":"1989","journal-title":"Acta Neuropathol"},{"key":"10.1111\/ajt.12153_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/13550289809113482","article-title":"Progressive multifocal leukoencephalopathy in patients with HIV infection","volume":"4","author":"Berger","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1111\/ajt.12153_bib18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/598335","article-title":"Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study","volume":"48","author":"Khanna","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.12153_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/WNL.52.3.623","article-title":"HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy","volume":"52","author":"Clifford","year":"1999","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1111\/ajt.12153_bib20","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3949\/ccjm.78.s2.02","article-title":"History and current concepts in the pathogenesis of PML","volume":"78","author":"Major","year":"2011","journal-title":"Cleveland Clin J Med"},{"issue":"Suppl 2","key":"10.1111\/ajt.12153_bib21","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.3949\/ccjm.78.s2.05","article-title":"Multiple sclerosis, natalizumab, and PML: Helping patients decide","volume":"78","author":"Rudick","year":"2011","journal-title":"Cleveland Clin J Med"},{"key":"10.1111\/ajt.12153_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1352458511435105","article-title":"Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab","volume":"18","author":"Sorensen","year":"2012","journal-title":"Mult Scler"},{"key":"10.1111\/ajt.12153_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/01.wnl.0000319648.65173.7a","article-title":"Quantitative risk-benefit analysis of natalizumab","volume":"71","author":"Thompson","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/ajt.12153_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clindermatol.2007.10.027","article-title":"Efalizumab in the treatment of psoriasis: Mode of action, clinical indications, efficacy, and safety","volume":"26","author":"Schon","year":"2008","journal-title":"Clin Dermatol"},{"issue":"Suppl 2","key":"10.1111\/ajt.12153_bib25","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.3949\/ccjm.78.s2.07","article-title":"PML and rheumatology: The contribution of disease and drugs","volume":"78","author":"Molloy","year":"2011","journal-title":"Cleveland Clin J Med"},{"key":"10.1111\/ajt.12153_bib26","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1111\/ajt.12153_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archneur.62.2.258","article-title":"Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis","volume":"62","author":"Monson","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1111\/ajt.12153_bib28","first-page":"267","article-title":"Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates","volume":"13","author":"Reinsmoen","year":"2012","journal-title":"Discov Med"},{"key":"10.1111\/ajt.12153_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.smim.2011.08.021","article-title":"Humoral immunity and antibody-mediated rejection in solid organ transplantation","volume":"23","author":"Montgomery","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1111\/ajt.12153_bib30","doi-asserted-by":"crossref","first-page":"201754","DOI":"10.1155\/2012\/201754","article-title":"Antibody-mediated rejection: Pathogenesis, prevention, treatment, and outcomes","volume":"2012","author":"Blume","year":"2012","journal-title":"J Transplant"},{"key":"10.1111\/ajt.12153_bib31","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: A report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1111\/ajt.12153_bib32","first-page":"888","article-title":"Progressive multifocal leukoencephalopathy fifty-seven months after heart transplantation","volume":"10","author":"Flomenbaum","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/ajt.12153_bib33","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/j.1432-2277.2010.01190.x","article-title":"Progressive multifocal leukoencephalopathy in liver transplant recipients: A case report and review of the literature","volume":"24","author":"Verhelst","year":"2011","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12153_bib34","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","article-title":"Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation","volume":"86","author":"Neff","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12153_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00277-007-0411-6","article-title":"Progressive multifocal leukoencephalopathy: Report of three cases in HIV-negative hematological patients and review of literature","volume":"87","author":"Pelosini","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1111\/ajt.12153_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0961203311416693","article-title":"Progressive multifocal leukoencephalopathy associated with mycophenolate mofetil treatment in a woman with lupus and CD4+ T-lymphocyte deficiency","volume":"21","author":"Pavlovic","year":"2012","journal-title":"Lupus"},{"key":"10.1111\/ajt.12153_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00007890-199510270-00019","article-title":"Cyclosporine-related leukoencephalopathy and PML in a liver transplant recipient","volume":"60","author":"Aksamit","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12153_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.22408","article-title":"Progressive multifocal leukoencephalopathy in transplant recipients","volume":"70","author":"Mateen","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1111\/ajt.12153_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000337339","article-title":"Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation","volume":"2","author":"Baek","year":"2012","journal-title":"Nephron Extra"},{"key":"10.1111\/ajt.12153_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","article-title":"Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function","volume":"72","author":"Khatri","year":"2009","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1111\/ajt.12153_bib41","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.3949\/ccjm.78.s2.09","article-title":"A rational approach to PML for the clinician","volume":"78","author":"Calabrese","year":"2011","journal-title":"Cleveland Clin J Med"},{"key":"10.1111\/ajt.12153_bib42","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM199805073381903","article-title":"Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team","volume":"338","author":"Hall","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12153_bib43","first-page":"404","article-title":"[The inefficacy of zidovudine (AZT) in progressive multifocal leukoencephalopathy (PML) associated with the acquired immunodeficiency syndrome (AIDS)]","volume":"187","author":"Garrote","year":"1990","journal-title":"Revista Clinica Espanola"},{"key":"10.1111\/ajt.12153_bib44","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1097\/00002030-200209060-00012","article-title":"A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS","volume":"16","author":"Marra","year":"2002","journal-title":"Aids"},{"key":"10.1111\/ajt.12153_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.64.2.169","article-title":"Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: Possible interventions","volume":"64","author":"Stuve","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1111\/ajt.12153_bib46","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","article-title":"Identification and characterization of mefloquine efficacy against JC virus in vitro","volume":"53","author":"Brickelmaier","year":"2009","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1111\/ajt.12153_bib47","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"Elphick","year":"2004","journal-title":"Science"},{"key":"10.1111\/ajt.12153_bib48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1086\/520514","article-title":"Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera","volume":"196","author":"Verma","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/ajt.12153_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/bmt.2010.221","article-title":"Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient","volume":"46","author":"Balduzzi","year":"2011","journal-title":"Bone Marrow Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12153","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522259140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522259140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.12153\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:01:10Z","timestamp":1761627670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522259140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1600613522259140"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12153","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody-Mediated Rejection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}